Skip to main content
. Author manuscript; available in PMC: 2019 Mar 25.
Published in final edited form as: J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jun 6;901:25–33. doi: 10.1016/j.jchromb.2012.05.036

Table 9.

Example of incurred patient sample re-analysis.

Patient sampling schedule (h) Measured [MX] (ng/ml) E (ng/ml)a %REb
First analysis Re-analysis after 9 months
Pre-dose no peak no peak not applicable not applicable
0.250 5.36 5.69 0.33 6.2
0.500 8.95 10.2 1.25 14.0
0.750 16.2 18.2 2.0 12.3
0.983 20.5 22.1 1.6 7.8
1.17 25 27.1 2.1 8.4
2.00 24.2 24.3 0.1 0.4
4.00 18.3 20 1.7 9.3
6.00 19 19.5 0.5 2.6
8.00 18.9 17.5 −1.4 −7.4
12.0 15.6 16.2 0.6 3.8
24.0 13.3 13.2 −0.1 −0.8
48.0 9.46 10 0.54 5.7
72.0 6.56 6.46 −0.10 −1.5
96.0 4.46 4.76 0.3 6.7
120 3.55 3.69 0.14 3.9
168 2.11 2.29 0.18 8.5
192 1.55 1.76 0.21 13.5
216 1.22 1.39 0.17 13.9
a

E (error) = value of first analysis − value of re-analysis

b

%RE (percent relative error) = (error/value of first analysis) × 100%